Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-24
Seventy-two percent of infants born during the 2023-24 respiratory virus season were immunized against respiratory syncytial virus (RSV) via antenatal RSV vaccine or nirsevimab receipt.